DK2323638T3 - Sammensætninger og fremgangsmåder til behandling af osteoartritis - Google Patents
Sammensætninger og fremgangsmåder til behandling af osteoartritisInfo
- Publication number
- DK2323638T3 DK2323638T3 DK09790642.4T DK09790642T DK2323638T3 DK 2323638 T3 DK2323638 T3 DK 2323638T3 DK 09790642 T DK09790642 T DK 09790642T DK 2323638 T3 DK2323638 T3 DK 2323638T3
- Authority
- DK
- Denmark
- Prior art keywords
- procedures
- compositions
- treating osteoarthritis
- osteoarthritis
- treating
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 201000008482 osteoarthritis Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8218508P | 2008-07-18 | 2008-07-18 | |
| PCT/US2009/051169 WO2010009474A1 (en) | 2008-07-18 | 2009-07-20 | Compositions and methods for treating osteoarthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2323638T3 true DK2323638T3 (da) | 2014-08-11 |
Family
ID=41059867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09790642.4T DK2323638T3 (da) | 2008-07-18 | 2009-07-20 | Sammensætninger og fremgangsmåder til behandling af osteoartritis |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9629382B2 (da) |
| EP (1) | EP2323638B1 (da) |
| JP (2) | JP2011528668A (da) |
| CN (1) | CN102159197A (da) |
| AU (1) | AU2009270718B2 (da) |
| BR (1) | BRPI0915986A2 (da) |
| CA (1) | CA2731067C (da) |
| DK (1) | DK2323638T3 (da) |
| ES (1) | ES2480193T3 (da) |
| RU (1) | RU2619553C2 (da) |
| WO (1) | WO2010009474A1 (da) |
| ZA (1) | ZA201101055B (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9629382B2 (en) | 2008-07-18 | 2017-04-25 | Hill's Pet Nutrition, Inc. | Compositions and methods for treating osteoarthritis |
| US20110159500A1 (en) * | 2009-12-29 | 2011-06-30 | Hill's Pet Nutrition, Inc. | Compositions including ginger for the amelioration or prevention of inflammatory conditions |
| CN102138961A (zh) * | 2010-02-02 | 2011-08-03 | 北京绿色金可生物技术股份有限公司 | 黑豆皮提取物在预防和治疗骨关节炎的产品中的应用 |
| CA2795575C (en) * | 2010-05-12 | 2017-02-28 | Hill's Pet Nutrition, Inc. | Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines |
| BR112012025772A2 (pt) * | 2010-05-12 | 2015-09-22 | Hills Pet Nutrition Inc | métodos de controle e profilaxia de inflamação e mitigação de condições inflamatórias em animais de estimação |
| WO2011143102A1 (en) * | 2010-05-12 | 2011-11-17 | Hill's Pet Nutrition, Inc. | Methods of diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in felines |
| US20130263294A1 (en) * | 2010-09-20 | 2013-10-03 | Bioiberica, S.A. | Markers for joint displasia, osteoarthritis and conditions secondary thereto |
| WO2012150504A1 (en) * | 2011-05-05 | 2012-11-08 | Life Science Nutrition As | Performance enhancing compositions and methods of use |
| BR112014007947A2 (pt) * | 2011-10-03 | 2017-04-18 | Univ Los Andes | método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5 |
| CN104039823A (zh) | 2011-12-19 | 2014-09-10 | 希尔氏宠物营养品公司 | 用于诊断和治疗伴侣动物的甲状腺机能亢进的组合物和方法 |
| US20140220006A1 (en) * | 2013-02-01 | 2014-08-07 | Meso Scale Technologies, Llc | Lung cancer biomarkers |
| KR20250156824A (ko) * | 2015-01-06 | 2025-11-03 | 데이비드 버톤 | 모바일 웨어러블 모니터링 시스템 |
| PL3280423T3 (pl) * | 2015-04-08 | 2023-12-27 | Microvascular Health Solutions, LLC | Kompozycje i sposoby do synergistycznego leczenia glikokaliksu |
| EP3446127A4 (en) * | 2016-04-20 | 2020-01-22 | Crescendo Bioscience, Inc. | BIOMARKERS AND METHODS FOR ASSESSING RESPONSE TO INFLAMMATORY DISEASE TREATMENT |
| US20190316096A1 (en) * | 2016-12-28 | 2019-10-17 | Kyowa Hakko Kirin Co | Method for selecting cell |
| EP3612570A4 (en) | 2017-04-17 | 2021-01-13 | The University of Chicago | POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS |
| CN107412240A (zh) * | 2017-07-24 | 2017-12-01 | 冯纪敏 | 一种组合物及其应用 |
| AU2017440239B2 (en) * | 2017-11-17 | 2021-06-24 | Hill's Pet Nutrition, Inc. | Compositions comprising omega-3 polyunsaturated and medium chain fatty acids |
| JP7402225B2 (ja) | 2018-05-11 | 2023-12-20 | ロード アイランド ホスピタル | ヌクレオシド系逆転写酵素阻害剤を用いて関節障害を処置するための組成物および方法 |
| CN109266738A (zh) * | 2018-11-19 | 2019-01-25 | 山西中医药大学 | 类风湿关节炎大鼠炎症因子检测引物及其方法 |
| CN109680046B (zh) * | 2019-01-17 | 2021-08-10 | 浙江大学 | 骨关节炎第一亚型的生物标记物以及用途 |
| CN109965124A (zh) * | 2019-03-29 | 2019-07-05 | 华熙生物科技股份有限公司 | 一种宠物食品及其制备方法 |
| CN110511937B (zh) * | 2019-08-05 | 2021-07-09 | 华南农业大学 | Snf7基因及其防治瓢虫的应用 |
| US20230030915A1 (en) * | 2019-12-16 | 2023-02-02 | Hill's Pet Nutrition, Inc. | Pet Food Compositions |
| US20240382518A1 (en) * | 2021-09-17 | 2024-11-21 | Seoul National University R&Db Foundation | Pharmaceutical composition and health functional food for prevention or treatment of osteoarthritis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2210705T5 (es) * | 1998-03-19 | 2011-02-15 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Composición combinada que comprende una l-carnitina o una alcanoil-l-carnitina, un glucosaminoglucano y/o un constituyente del mismo. |
| US6506785B2 (en) * | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| PL346860A1 (en) * | 1998-09-08 | 2002-03-11 | Monsanto Co | Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6277842B1 (en) * | 2000-10-17 | 2001-08-21 | James Alexander Carthron | Dietary supplemental method for fat and weight reduction |
| US20020099032A1 (en) * | 2000-11-10 | 2002-07-25 | Kiyotsugu Higashi | Preparations and method of producing the same |
| WO2005000331A2 (en) * | 2003-06-04 | 2005-01-06 | Mucosal Therapeutics, Inc. | Compositions for the treatment and prevention of degenerative joint disorders |
| US8633247B2 (en) | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Method for decreasing cartilage damage in dogs |
| ES2310757T3 (es) * | 2003-08-11 | 2009-01-16 | Hill's Pet Nutrition Inc. | Acidos grasos omega-3 para el tratamiento de la artrosis canina. |
| US8633246B2 (en) | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Omega-3 fatty acids for osteoarthritis |
| US8377904B2 (en) * | 2004-02-09 | 2013-02-19 | Hill's Pet Nutrition, Inc. | Composition and method for use in cartilage affecting conditions |
| JP5667737B2 (ja) * | 2004-07-01 | 2015-02-12 | ネステク ソシエテ アノニム | イヌ変形性関節症食餌製剤 |
| CN102784396B (zh) * | 2004-11-09 | 2015-07-29 | 希尔氏宠物营养品公司 | 抗氧化剂用于基因调节的用途 |
| CN101247833B (zh) * | 2005-06-29 | 2013-02-13 | 希尔氏宠物营养品公司 | 预防和治疗炎性疾病的方法和组合物 |
| JP2009522553A (ja) * | 2005-12-28 | 2009-06-11 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 体重状態または素因の診断方法 |
| US8021659B2 (en) * | 2006-04-28 | 2011-09-20 | Naidu Lp | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
| US9629382B2 (en) | 2008-07-18 | 2017-04-25 | Hill's Pet Nutrition, Inc. | Compositions and methods for treating osteoarthritis |
-
2009
- 2009-07-20 US US13/054,745 patent/US9629382B2/en active Active
- 2009-07-20 DK DK09790642.4T patent/DK2323638T3/da active
- 2009-07-20 CN CN2009801374555A patent/CN102159197A/zh active Pending
- 2009-07-20 BR BRPI0915986A patent/BRPI0915986A2/pt not_active IP Right Cessation
- 2009-07-20 WO PCT/US2009/051169 patent/WO2010009474A1/en not_active Ceased
- 2009-07-20 CA CA2731067A patent/CA2731067C/en active Active
- 2009-07-20 JP JP2011518960A patent/JP2011528668A/ja active Pending
- 2009-07-20 ES ES09790642.4T patent/ES2480193T3/es active Active
- 2009-07-20 EP EP09790642.4A patent/EP2323638B1/en active Active
- 2009-07-20 AU AU2009270718A patent/AU2009270718B2/en not_active Ceased
- 2009-07-20 RU RU2011106033A patent/RU2619553C2/ru not_active IP Right Cessation
-
2011
- 2011-02-09 ZA ZA2011/01055A patent/ZA201101055B/en unknown
-
2014
- 2014-08-20 JP JP2014167333A patent/JP6047128B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20110183006A1 (en) | 2011-07-28 |
| JP2014237709A (ja) | 2014-12-18 |
| US9629382B2 (en) | 2017-04-25 |
| EP2323638B1 (en) | 2014-05-07 |
| AU2009270718B2 (en) | 2012-09-06 |
| EP2323638A1 (en) | 2011-05-25 |
| WO2010009474A1 (en) | 2010-01-21 |
| ZA201101055B (en) | 2014-07-30 |
| RU2619553C2 (ru) | 2017-05-16 |
| ES2480193T3 (es) | 2014-07-25 |
| BRPI0915986A2 (pt) | 2015-11-03 |
| CA2731067A1 (en) | 2010-01-21 |
| JP6047128B2 (ja) | 2016-12-21 |
| JP2011528668A (ja) | 2011-11-24 |
| CN102159197A (zh) | 2011-08-17 |
| AU2009270718A1 (en) | 2010-01-21 |
| RU2011106033A (ru) | 2012-08-27 |
| CA2731067C (en) | 2013-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2323638T3 (da) | Sammensætninger og fremgangsmåder til behandling af osteoartritis | |
| DK2894165T3 (da) | Fremgangsmåder og sammensætninger til behandling af komplementforbundne forstyrrelser | |
| DK2470656T3 (da) | Sammensætning til hæmning af genekspression og anvendelser heraf | |
| DK2361090T3 (da) | Sammensætninger til behandling af centralt medieret kvalme og opkastning | |
| DK3181134T3 (da) | Bifidobakterier til behandling af diabetes og relaterede tilstande | |
| DK3128014T3 (da) | Midler og fremgangsmåder til sterilisering af biofunktionelle sammensætninger | |
| DK2252342T3 (da) | Indretninger og fremgangsmåder til behandling af skadet væv | |
| DK2061561T3 (da) | Sammensætninger til behandling af cancer | |
| DK2212070T3 (da) | Fremgangsmåde til behandling af træ | |
| DK2326357T3 (da) | Sammensætning og fremgangsmåde til behandling af vævsdefekter | |
| DK2365988T4 (da) | Tværbundne kationsbytningspolymerer, sammensætninger og anvendelse til behandling af hyperkaliæmi | |
| DK2429574T3 (da) | Sammensætninger og fremgangsmåder til behandling af hæmatologiske cancere der targeterer sirp-cd47-interaktionen | |
| DK3795573T3 (da) | Bestemte triazolopyraziner, sammensætninger deraf og fremgangsmåder til anvendelse deraf | |
| DK2365802T3 (da) | Mikrokapsler af rapamycin og anvendelse til behandling af cancer | |
| DK2187880T3 (da) | Sammensætninger og fremgangsmåder til behandling af makuladegeneration | |
| DK2310034T3 (da) | Peptider til behandling af beta-amyloidose | |
| DK3272879T3 (da) | Transposonendesammensætninger og fremgangsmåder til modificering af nukleinsyrer | |
| DK2293816T3 (da) | Fremgangsmåder til behandling af reumatoid arthritis | |
| DK3260118T3 (da) | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion | |
| DK3443957T3 (da) | Forbindelser og sammensætninger til behandling af cancer | |
| DK2398902T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af cancer | |
| DK2350116T3 (da) | Behandling af biofilm | |
| DK2270818T3 (da) | Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten | |
| DK2245032T3 (da) | Folater, sammensætninger og anvendelser deraf | |
| DK2099489T3 (da) | Sammensætninger og fremgangsmåder til behandling af en neoplasme |